|  | Cancer | Lymphoma

B Cell vs. T Cell Development: Lineage Commitment in the Bone Marrow and Thymus

Lymphocyte lineage commitment is governed by transcriptional networks, microenvironmental signals, and receptor signaling.

Common Progenitor → B vs. T Fate Decision

  • HSC → MPP → CLP (Common Lymphoid Progenitor) in bone marrow.
  • B-cell commitment (in bone marrow):
    • Transcription factors: EBF1, PAX5, E2A → activate B-lineage genes (CD19, CD79a, Igα/β).
    • IL-7 from stromal cells → survival, proliferation, V(D)J recombination (IgH then IgL).
    • Pre-BCR checkpoint → light chain rearrangement → immature B cell (IgM+).
    • Negative selection (central tolerance) → transitional B cells → spleen → mature follicular/marginal zone B cells.
  • T-cell commitment (in thymus):
    • CLP → thymus (via blood) → DN (double-negative) stages.
    • Notch1 signaling (from thymic epithelium) → GATA3, TCF1, BCL11B → T-lineage specification; represses B/myeloid genes.
    • β-selection (pre-TCR) → proliferation, CD4/CD8 upregulation (DP).
    • Positive selection (self-MHC recognition) → CD4+ or CD8+ SP.
    • Negative selection (high-affinity self-reactivity) → apoptosis.
    • Treg development (Foxp3+).
    • Export to periphery.

Key Signaling Pathways

  • B-cell: BCR → SYK → BTK → PLCγ2 → Ca²⁺/NF-κB/MAPK. BTK mutations → X-linked agammaglobulinemia.
  • T-cell: TCR → LCK/ZAP70 → LAT/SLP76 → PLCγ1 → Ca²⁺/NFAT, Ras/MAPK, PKCθ/NF-κB. Co-stimulation (CD28) essential.

Clinical Correlates

  • SCID: defective IL-7R, JAK3, Artemis, RAG → absent T/B/NK.
  • DiGeorge (22q11): thymic aplasia → T-cell lymphopenia.
  • Autoimmunity: defective central/peripheral tolerance.

Lymphoma - Related Articles